Cytokeratin 19 anticorps (Biotin)
-
- Antigène Voir toutes Cytokeratin 19 (KRT19) Anticorps
- Cytokeratin 19 (KRT19) (Keratin 19 (KRT19))
-
Reactivité
- Humain
-
Hôte
- Souris
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp Cytokeratin 19 est conjugé à/à la Biotin
-
Application
- Western Blotting (WB), ELISA, Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunoprecipitation (IP), Immunocytochemistry (ICC)
- Specificité
- The mouse monoclonal antibody A53-B/A2 recognizes the rod domain of cytokeratin 19 (40 kDa), an intracellular antigen constituting intermmediate cytoskeleton filaments. Cytokeratin 19 is not expressed in hepatocytes, it is often co-expressed with cytokeratin 7.
- Réactivité croisée (Details)
- Human
- Purification
- Purified antibody is conjugated with biotin LC-NHS ester under optimum conditions and unconjugated antibody and free biotin are removed by size-exclusion chromatography.
- Immunogène
- MCF-7 human breast adenocarcinoma cell line
- Clone
- A53-B-A2
- Isotype
- IgG2a
- Top Product
- Discover our top product KRT19 Anticorps primaire
-
-
- Indications d'application
-
Flow cytometry: Recommended dilution: 1-5 μg/mL, intracellular staining.
Western blotting: Recommended dilution: 1-2 μg/mL. - Commentaires
-
The purified antibody is conjugated with Biotin-LC-NHS under optimum conditions. The reagent is free of unconjugated biotin.
- Restrictions
- For Research Use only
-
- Concentration
- 1 mg/mL
- Buffer
- Phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Conseil sur la manipulation
-
Do not freeze.
Avoid prolonged exposure to light. - Stock
- 4 °C
- Stockage commentaire
- Store at 2-8°C. Do not freeze.
-
-
Patterns of cytokeratin and vimentin expression in the human eye." dans: Histochemistry, Vol. 89, Issue 4, pp. 369-77, (1988) (PubMed).
: "Monoclonal anti-cytokeratin antibody from a hybridoma clone generated by electrofusion." dans: European journal of cancer & clinical oncology, Vol. 21, Issue 6, pp. 733-40, (1985) (PubMed).
: "
-
Patterns of cytokeratin and vimentin expression in the human eye." dans: Histochemistry, Vol. 89, Issue 4, pp. 369-77, (1988) (PubMed).
-
- Antigène
- Cytokeratin 19 (KRT19) (Keratin 19 (KRT19))
- Autre désignation
- Cytokeratin 19 (KRT19 Produits)
- Synonymes
- anticorps CK19, anticorps K19, anticorps K1CS, anticorps AI663979, anticorps EndoC, anticorps Krt-1.19, anticorps Krt1-19, anticorps Ka19, anticorps k19, anticorps ck19, anticorps k1cs, anticorps krt9, anticorps krt15, anticorps MGC76282, anticorps GK-19, anticorps MGC83069, anticorps KRT19, anticorps keratin 19, anticorps keratin 19 L homeolog, anticorps keratin, type I cytoskeletal 19, anticorps KRT19, anticorps Krt19, anticorps krt19, anticorps krt19.L, anticorps LOC100344434, anticorps LOC101117946
- Sujet
- Keratin 19,Cytokeratins are a subfamily of intermediate filaments and characterized by remarkable biochemical diversity. They are represented in epithelial tissues by at least 20 different polypeptides, molecular weight between 40 kDa and 68 kDa. The individual cytokeratin polypeptides are designated 1 to 20 and divided into the type I (acidic cytokeratins 9-20) and type II (basic to neutral cytokeratins 1-8) families.,K19, CK19, CYK19, KRT19, K1CS
- ID gène
- 3880
- UniProt
- P08727
-